Singapore markets closed
  • Straits Times Index

    3,192.35
    -16.51 (-0.51%)
     
  • S&P 500

    4,288.39
    +0.34 (+0.01%)
     
  • Dow

    33,433.35
    -74.15 (-0.22%)
     
  • Nasdaq

    13,307.77
    +88.45 (+0.67%)
     
  • Bitcoin USD

    27,576.81
    -727.62 (-2.57%)
     
  • CMC Crypto 200

    589.53
    -14.01 (-2.32%)
     
  • FTSE 100

    7,535.75
    +25.03 (+0.33%)
     
  • Gold

    1,842.90
    -4.30 (-0.23%)
     
  • Crude Oil

    88.92
    +0.10 (+0.11%)
     
  • 10-Yr Bond

    4.6830
    0.0000 (0.00%)
     
  • Nikkei

    31,237.94
    -521.94 (-1.64%)
     
  • Hang Seng

    17,331.22
    -478.44 (-2.69%)
     
  • FTSE Bursa Malaysia

    1,420.01
    +1.25 (+0.09%)
     
  • Jakarta Composite Index

    6,940.89
    -20.57 (-0.30%)
     
  • PSE Index

    6,305.99
    +1.46 (+0.02%)
     

Is Invitae Stock a Buy Now?

Is Invitae Stock a Buy Now?

Invitae (NYSE: NVTA) shares have plummeted more than 80% this year. The genetic testing company has grown revenue over the years, but it hasn't been able to turn that revenue into profit. Instead, it's burned through cash -- and left investors wondering when and if the company can make it to profitability.